{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:46:23Z","timestamp":1768398383894,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.beem.2009.07.003","type":"journal-article","created":{"date-parts":[[2009,11,27]],"date-time":"2009-11-27T13:44:35Z","timestamp":1259329475000},"page":"693-702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Immune reconstitution syndrome and the thyroid"],"prefix":"10.1016","volume":"23","author":[{"given":"Anthony","family":"Weetman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"343","key":"10.1016\/j.beem.2009.07.003_bib1","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM200010263431707","article-title":"Graves' disease","volume":"26","author":"Weetman","year":"2000","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2009.07.003_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/gene.2008.26","article-title":"Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves' disease","volume":"9","author":"Zeitlin","year":"2008","journal-title":"Genes and Immunity"},{"key":"10.1016\/j.beem.2009.07.003_bib3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1530\/eje.0.1500605","article-title":"The environment and autoimmune thyroid diseases","volume":"150","author":"Prummel","year":"2004","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2009.07.003_bib4","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1182\/blood.V99.3.768","article-title":"Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?","volume":"99","author":"Burt","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beem.2009.07.003_bib5","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.bmt.1701437","article-title":"Autoimmune diseases and autoimmunity post-bone marrow transplantation","volume":"22","author":"Sherer","year":"1998","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.beem.2009.07.003_bib6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2141.1990.00010.x-i1","article-title":"Adoptive transfer of hyperthyroidism and autoimmune thyroiditis following allogeneic bone marrow transplantation for chronic myeloid leukaemia","volume":"74","author":"Aldouri","year":"1990","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.beem.2009.07.003_bib7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.bmt.1700955","article-title":"Immune thyroiditis after transplantation of allogeneic CD34+ selected peripheral blood cells","volume":"20","author":"Karthaus","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.beem.2009.07.003_bib8","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/sj.bmt.1701760","article-title":"Adoptive autoimmune hy perthyroidism following allogeneic stem cell transplantation from an HLA-identical sibling with Graves' disease","volume":"23","author":"Berisso","year":"1999","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.beem.2009.07.003_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-131-2-199907200-00023","article-title":"Graves' disease after bone marrow transplantation","volume":"131","author":"Takeshita","year":"1999","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.beem.2009.07.003_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1507\/endocrj.51.439","article-title":"Appearance of thyroid stimulating and blocking immunoglobulins after bone marrow transplantation: presentation of two contrasting cases","volume":"51","author":"Yamamori","year":"2004","journal-title":"Endocrine Journal"},{"key":"10.1016\/j.beem.2009.07.003_bib11","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/sj.bmt.1703291","article-title":"Relapse of Graves' disease after successful allogeneic bone marrow transplantation","volume":"28","author":"Hsiao","year":"2001","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.beem.2009.07.003_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/332323a0","article-title":"Reshaping human antibodies for therapy","volume":"332","author":"Riechmann","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.beem.2009.07.003_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/brain\/119.1.225","article-title":"Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis","volume":"119","author":"Moreau","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.beem.2009.07.003_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/10245330400026139","article-title":"A review of Campath in autoimmune disease: biologic therapy in the gray zone between immunosuppression and immunoablation","volume":"10","author":"Reiff","year":"2005","journal-title":"Hematology"},{"key":"10.1016\/j.beem.2009.07.003_bib15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0140-6736(94)91339-0","article-title":"Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis","volume":"344","author":"Moreau","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2009.07.003_bib16","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0140-6736(99)02429-0","article-title":"Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis","volume":"354","author":"Coles","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2009.07.003_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00415-008-0696-y","article-title":"Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis","volume":"255","author":"Hirst","year":"2008","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.beem.2009.07.003_bib18","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1056\/NEJMoa0802670","article-title":"Alemtuzumab vs. interferon beta-1a in early multiple sclerosis","volume":"359","author":"CAMMS223 Trial Investigators","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2009.07.003_bib19","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/ard.2007.081661","article-title":"Long-term follow-up of relapsing\/refractory anti-neutrophil cytoplasm antibody associated vasculitis treated with the lymphocyte depleting antibody alemtuzumab (CAMPATH-1H)","volume":"67","author":"Walsh","year":"2008","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.beem.2009.07.003_bib20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2141.2007.06687.x","article-title":"The development of sarcoidosis with the use of alemtuzumab - clues to T-cell immune reconstitution","volume":"138","author":"Thachil","year":"2007","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.beem.2009.07.003_bib21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/art.23122","article-title":"Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomes","volume":"58","author":"Lorenzi","year":"2008","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.beem.2009.07.003_bib22","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1600-6143.2006.01258.x","article-title":"Autoimmune thyroid disease after renal transplantation using depletional induction with alemtuzumab","volume":"6","author":"Kirk","year":"2006","journal-title":"American Journal of Transplantation"},{"key":"10.1016\/j.beem.2009.07.003_bib23","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1056\/NEJMc0800484","article-title":"Anti-glomerular basement membrane disease after alemtuzumab","volume":"359","author":"Clatworthy","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2009.07.003_bib24","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/brain\/123.6.1102","article-title":"Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey","volume":"123","author":"Broadley","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.beem.2009.07.003_bib25","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00415-003-1053-9","article-title":"Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis","volume":"250","author":"Niederwieser","year":"2003","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.beem.2009.07.003_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/gene.2008.82","article-title":"CD226 Gly307Ser association with multiple autoimmune diseases","volume":"10","author":"Hafler","year":"2009","journal-title":"Genes and Immunity"},{"key":"10.1016\/j.beem.2009.07.003_bib27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/eje.0.1410325","article-title":"Effect of 1-year treatment with interferon-beta1b on thyroid function and autoimmunity in patients with multiple sclerosis","volume":"141","author":"Monzani","year":"1999","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2009.07.003_bib28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1212\/WNL.55.4.549","article-title":"Long-term interferon beta-1b therapy for MS: is routine thyroid assessment always useful?","volume":"55","author":"Monzani","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.beem.2009.07.003_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-510X(01)00637-2","article-title":"Betaferon Safety Trial (BEST) Study Group. Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study","volume":"193","author":"Durelli","year":"2001","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.beem.2009.07.003_bib30","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2004-2326","article-title":"Long-term follow-up of 106 multiple sclerosis patients undergoing interferon-beta 1a or 1b therapy: predictive factors of thyroid disease development and duration","volume":"90","author":"Caraccio","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.07.003_bib31","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1212\/01.WNL.0000154522.86947.86","article-title":"European Study Group on Interferon Beta-1b in SPMS. Interferon beta-1b treatment does not induce autoantibodies","volume":"64","author":"Polman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.beem.2009.07.003_bib32","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.clinthera.2007.06.002","article-title":"RNF Study Group. Immunogenicity and tolerability of an investigational formulation of interferon-beta1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase IIIb study in adults with multiple sclerosis","volume":"29","author":"Giovannoni","year":"2007","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.beem.2009.07.003_bib33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1126\/science.277.5322.112","article-title":"Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease","volume":"277","author":"Autran","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.beem.2009.07.003_bib34","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1086\/519978","article-title":"Thyroid function abnormalities in HIV-infected patients","volume":"45","author":"Hoffmann","year":"2007","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.beem.2009.07.003_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1468-1293.2007.00422.x","article-title":"No association between HIV disease and its treatment and thyroid function","volume":"8","author":"Madge","year":"2007","journal-title":"HIV Medicine"},{"key":"10.1016\/j.beem.2009.07.003_bib36","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2265.2006.02472.x","article-title":"Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study","volume":"64","author":"Madeddu","year":"2006","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2009.07.003_bib37","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(05)60398-4","article-title":"Delayed occurrence of Graves' disease after immune restoration with HAART. Highly active antiretroviral therapy","volume":"352","author":"Gilquin","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2009.07.003_bib38","first-page":"4254","article-title":"Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients","volume":"85","author":"Jubault","year":"2000","journal-title":"J Clinics in Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.07.003_bib39","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00002030-200101050-00026","article-title":"Alopecia universalis and Graves' disease in the setting of immune restoration after highly active antiretroviral therapy","volume":"15","author":"Sereti","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.beem.2009.07.003_bib40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/088922204773004879","article-title":"Graves' disease during immune reconstitution after highly active antiretroviral therapy for HIV infection: evidence of thymic dysfunction","volume":"20","author":"French","year":"2004","journal-title":"AIDS Research and Human Retroviruses"},{"key":"10.1016\/j.beem.2009.07.003_bib41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/01.md.0000159082.45703.90","article-title":"Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease","volume":"84","author":"Chen","year":"2005","journal-title":"Medicine"},{"key":"10.1016\/j.beem.2009.07.003_bib42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/vim.2006.19.102","article-title":"Graves' disease as an immune reconstitution syndrome in an HIV-1-positive patient commencing effective antiretroviral therapy: case report and literature review","volume":"19","author":"Knysz","year":"2006","journal-title":"Viral Immunology"},{"issue":"60","key":"10.1016\/j.beem.2009.07.003_bib43","first-page":"62","article-title":"Thyrotoxic periodic paralysis in a Polynesian male following highly active antiretroviral therapy for HIV infection","volume":"66","author":"Brown","year":"2007","journal-title":"Hawaii Medical Journal"},{"key":"10.1016\/j.beem.2009.07.003_bib44","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.semarthrit.2005.03.007","article-title":"Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease","volume":"35","author":"Calabrese","year":"2005","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.beem.2009.07.003_bib45","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1086\/524082","article-title":"De novo autoimmune hepatitis during immune reconstitution in an HIV-infected patient receiving highly active antiretroviral therapy","volume":"46","author":"O'Leary","year":"2008","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.beem.2009.07.003_bib46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1386-6532(01)00200-1","article-title":"Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy","volume":"22","author":"Price","year":"2001","journal-title":"Journal of Clinical Virology"},{"key":"10.1016\/j.beem.2009.07.003_bib47","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/j.jinf.2005.02.031","article-title":"Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature","volume":"51","author":"Skiest","year":"2005","journal-title":"The Journal of Infection"},{"key":"10.1016\/j.beem.2009.07.003_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1600-065X.1996.tb00901.x","article-title":"Organ-specific autoimmunity induced by lymphopenia","volume":"149","author":"Gleeson","year":"1996","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.beem.2009.07.003_bib49","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4049\/jimmunol.142.2.471","article-title":"Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease","volume":"142","author":"Sakaguchi","year":"1989","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.beem.2009.07.003_bib50","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ni1184","article-title":"Natural regulatory T cells and self-tolerance","volume":"6","author":"Schwartz","year":"2005","journal-title":"Nature Immunology"},{"key":"10.1016\/j.beem.2009.07.003_bib51","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1056\/NEJMc0800484","article-title":"More on anti-glomerular basement membrane disease after alemtuzumab","volume":"359","author":"Clatworthy","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2009.07.003_bib52","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1002\/eji.200535075","article-title":"Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis","volume":"35","author":"Cox","year":"2005","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.beem.2009.07.003_bib53","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.4049\/jimmunol.173.6.3909","article-title":"A role for CD28 in lymphopenia-induced proliferation of CD4 T cells","volume":"173","author":"Hagen","year":"2004","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.beem.2009.07.003_bib54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.clim.2006.04.569","article-title":"Autoimmunity during lymphopenia: a two-hit model","volume":"120","author":"Krupica","year":"2006","journal-title":"Clinical Immunology"},{"key":"10.1016\/j.beem.2009.07.003_bib55","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0092-8674(04)00340-X","article-title":"Driven to autoimmunity: the nod mouse","volume":"117","author":"Gallegos","year":"2004","journal-title":"Cell"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X09000797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X09000797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:41:49Z","timestamp":1761496909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X09000797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1521690X09000797"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2009.07.003","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune reconstitution syndrome and the thyroid","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2009.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}